Law360, New York (February 17, 2012, 6:19 PM ET) -- Comments were due Friday on a proposed “sunshine” rule that would require drug and device companies to disclose payments made to doctors, and several industry groups filed comments urging the Centers for Medicare and Medicaid Services to back off on parts of the proposal.
CMS released the proposed rule in December. The Physician Payment Sunshine Act, as it's known, would require manufacturers of drugs, devices, biologics and medical supplies to report to CMS annually any payments or other “transfers of values” made to doctors or teaching...
PhRMA, Others Urge CMS To Back Off On Sunshine Rule
To view the full article, take a free trial now.
